Parallel Advisors’s Kailera Therapeutics KLRA Stock Holding History
Bought
Maintained
Sold
Other funds holding KLRA
Parallel Advisors's KLRA Position: Q3 2026 in Review
Parallel Advisors opened a new position in Kailera Therapeutics (KLRA) in Q3 2026: 900 shares worth $10.3K. The stake represents ﹤0.01% of the portfolio and ranks #3032 among its holdings.
132 funds tracked by Wall St. Rank hold KLRA as of Q3 2026.
- Parallel Advisors held 900 shares of Kailera Therapeutics worth $10.3K as of Q3 2026.
- Kailera Therapeutics was a new Parallel Advisors position in Q3 2026.
- Kailera Therapeutics made up ﹤0.01% of Parallel Advisors's portfolio in Q3 2026, its #3032 holding.
- 132 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q3 2026.
Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.